Clinical Trials in Salt Lake City

Showing 1961-1980 of 7,997 trials

A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain

NCT05761574

The purpose of this study is to evaluate how well a fixed combination of acetaminophen/naproxen sodium relieves postoperative dental pain compared with acetaminophen, naproxen sodium and placebo.

Pain

Johnson & Johnson Consumer Inc. (J&JCI)447 participantsStarted May 2023

Salt Lake City, Utah, United States

COMPLETEDPhase 1< 1 mile

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

NCT03884556

This is a phase 1/1b study of TTX-030, an antibody that inhibits CD39 enzymatic activity, leading to accumulation of pro-inflammatory adenosine triphosphate (ATP) and reduction of immunosuppressive adenosine, which may change the tumor microenvironment and promote anti-tumor immune response. This trial will study the safety, tolerability, pharmacokinetics, and anti-tumor activity of TTX-030 as a single agent and in combination with an approved anti-PD-1 immunotherapy and standard chemotherapies.

Solid TumorLymphoma

Trishula Therapeutics, Inc.56 participantsStarted Apr 2019

Orange, California, United States • Sacramento, California, United States • San Francisco, California, United States +13 more locations

A Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen and Naproxen Sodium in Postoperative Dental Pain

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Find Trials by Condition in Salt Lake City

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Vaginal Ecosystem and Network in the United States Study

Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy

A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

STEM-PD Open Label Extension (OLE)

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Predicting Local and Distant Recurrence in T1 Colorectal Cancer

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer